Mason, for cancer efficacy only (not cardio protection), based on the information you have to hand, what would be optimal dosing? I've always thought we would ideally administer low amounts (say 20mg/m2) twice weekly or something similar to this to ensure constant inhibition of FTO.
I guess the upcoming trial where we measure the m6a levels will help guide future cancer efficacy trials.
- Forums
- ASX - By Stock
- RAC
- Ann: Race Appoints George Clinical for Phase 1 Trial of RC220
Ann: Race Appoints George Clinical for Phase 1 Trial of RC220, page-118
-
- There are more pages in this discussion • 29 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RAC (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.53 |
Change
-0.060(3.79%) |
Mkt cap ! $259.9M |
Open | High | Low | Value | Volume |
$1.54 | $1.56 | $1.53 | $130.2K | 84.73K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 4993 | $1.53 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.58 | 10451 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 4993 | 1.525 |
1 | 12381 | 1.520 |
3 | 9872 | 1.510 |
3 | 11327 | 1.505 |
9 | 14363 | 1.500 |
Price($) | Vol. | No. |
---|---|---|
1.580 | 10451 | 1 |
1.595 | 6000 | 1 |
1.600 | 23239 | 1 |
1.630 | 6183 | 1 |
1.650 | 17029 | 2 |
Last trade - 16.10pm 18/10/2024 (20 minute delay) ? |
Featured News
RAC (ASX) Chart |